CareLit · DOI-Nachweis · Pneumologie
ENCORE: Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)
DOI 10.1055/s-0039-1678033
Bibliografische Angaben
Nachweis in CareLit
Autor:innenDSY Abdulla, RC Doebele, MJ Ahn, S Siena, A Drilon, MG Krebs, CC Lin, F de Braud, T John, DSW Tan, T Seto, R Dziadziusko, HT Arkenau, F Barlesi, C Rolfo, J Wolf, E Chow-Maneval, PS Multani, N Cui, T Riehl, BC Cho
ZeitschriftPneumologie
AusgabeS 01 S 01/2019
Jahrgang / SeitenJg. 73
Kernaussage aus der Literatur
Abstract-Vorschau
ENCORE: Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer (NSCLC)
Zitieren
Zitierempfehlung
DSY Abdulla, RC Doebele, MJ Ahn, S Siena, A Drilon, MG Krebs, CC Lin, F de Braud, T John, DSW Tan, T Seto, R Dziadziusko, HT Arkenau, F Barlesi, C Rolfo, J Wolf, E Chow-Maneval, PS Multani, N Cui, T Riehl, BC Cho (2019) ENCORE: Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer (NSCLC). Pneumologie, 73 (S 01 S 01). https://doi.org/10.1055/s-0039-1678033
Mit CareLit weiterarbeiten